For first time... Obesity rates in America have dropped. Thank you Semaglutide! [Reason]

Hey everyone — if you've been struggling with weight, here's news worth celebrating at the national level: obesity rates in America have finally started to DECLINE — and researchers are pointing directly at GLP-1 medications like Semaglutide as a major reason.

Between 2020 and 2023, U.S. obesity rates fell by about two percentage points. Two points sounds small until you understand the context: American obesity rates had risen relentlessly for DECADES. Every public-health campaign, every food-pyramid redesign, every "national conversation" — and the line only went up. Then these medications arrive at scale, and for the first time in living memory, the line bends DOWN.

The surge in semaglutide prescriptions over that exact period is the kind of coincidence that isn't one. When millions of people get access to a tool that actually works on the biology — quieting food noise, making fullness feel normal — the population math changes. We wrote recently about the estimated 10 trillion-calorie annual drop in U.S. consumption. This is what that looks like on a graph.

Why do I care so much about sharing this? Because it answers the "is this just a fad?" question with hard population data. Fads don't move national obesity rates. This is what a genuine medical turning point looks like — and we're still in the early chapters, with only a fraction of eligible people on treatment.

History is being made in real time. Our patients are part of it.

-Daryl

Book a FREE consult now <- Click There!

www.pnwmedicalgroup.com

Puyallup: 253-340-2270

Federal Way: 253-363-8877